文献速递血液净化与透析

医保扩展支付系统下腹膜透析患者结局

Peritoneal Dialysis Patient Outcomes under the Medicare Expanded Dialysis Prospective Payment System.
PubMed 文献 · Clin J Am Soc Nephrol · 2019-09-12

本研究评估美国医保预付费系统改革后腹膜透析(PD)扩展对患者结局的影响。前瞻性队列纳入90天时接受PD的ESKD患者,按改革前、 interim和改革期分组,随访3年。结果显示PD中断风险下降,死亡率稳定,尽管更多患者在PD经验较少的机构治疗。

要点

  • PD使用增加后,患者PD中断风险反而下降。
  • 死亡率在研究期间保持稳定。
  • 在PD经验较少的机构治疗与PD中断风险升高相关。

核心结论

  • 在PD使用扩大和机构PD经验下降的背景下,PD中断风险下降,且对死亡率无不良影响。

研究设计与样本

  • 前瞻性队列研究,纳入90天时接受PD的ESKD患者,按研究开始日期分为改革前(n=10,585)、 interim(n=7,832)和改革期(n=18,742),随访3年。

主要发现

  • 在PD经验较少的机构治疗的患者PD中断率更高(HR 1.16;95% CI 1.10-1.23,第一对第五分位)。
  • PD中断风险在interim后期(HR 0.88;95% CI 0.82-0.95)和改革期大部分时间下降(HR 0.85;95% CI 0.79-0.91至HR 0.94;95% CI 0.87-1.01)。
  • 死亡率风险在三个研究期间保持稳定。
  • 在PD经验较少机构治疗的患者比例从改革前的34%增至改革期的44%。

临床怎么用

  • 临床应关注在PD经验较少机构治疗的患者,其PD中断风险较高。
  • 医保支付改革后PD扩展未导致死亡率增加,可支持PD的推广。

局限性

  • 研究为观察性设计,可能存在残余混杂。
  • 未报告机构PD经验的具体定义(如患者数阈值)以外的细节。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: Peritoneal dialysis (PD) use increased in the United States with the introduction of a new Medicare prospective payment system in January 2011 that likely reduced financial disincentives for facility use of this home therapy. The expansion of PD to a broader population and facilities having less PD experience may have implications for patient outcomes. We assessed the impact of PD expansion on PD discontinuation and patient mortality. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: A prospective cohort study was conducted of patients treated with PD at 90 days of ESKD. Patients were grouped by study start date relative to the Medicare payment reform: prereform (July 1, 2008 to December 31, 2009; n=10,585), interim (January 1, 2010 to December 31, 2010; n=7832), and reform period (January 1, 2011 to December 31, 2012; n=18,742). Patient characteristics and facility PD experience were compared at baseline (day 91 of ESKD). Patients were followed for 3 years for the major outcomes of PD discontinuation and mortality using Cox proportional hazards models. RESULTS: Patient characteristics, including age, sex, race, ethnicity, rurality, cause of ESKD, and comorbidity, were similar or showed small changes across the three study periods. There was an increasing tendency for patients on PD to be treated in facilities with less PD experience (from 34% during the prereform period being treated in facilities averaging <14 patients on PD per year to 44% in the reform period). Patients treated in facilities with less PD experience had a higher rate of PD discontinuation than patients treated in facilities with the most experience (hazard ratio [HR], 1.16; 95% confidence interval [95% CI], 1.10 to 1.23 for the first versus fifth quintile of PD experience). Nevertheless, the risk of PD discontinuation fell during the late interim period (HR, 0.88; 95% CI, 0.82 to 0.95) and most of the reform period (from HR, 0.85; 95% CI, 0.79 to 0.91 to HR, 0.94; 95% CI, 0.87 to 1.01). Mortality risk was stable across the three study periods. CONCLUSIONS: In the context of expanding PD use and declining facility PD experience, the risk of PD discontinuation fell, and there was no adverse effect on mortality. PODCAST: This article contains a podcast at https://www.asn-online.org/media/podcast/CJASN/2019_09_12_CJN01610219.mp3.

来源:Clin J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Young EW, Kapke A, Ding Z, et al. Peritoneal Dialysis Patient Outcomes under the Medicare Expanded Dialysis Prospective Payment System. Clin J Am Soc Nephrol. 2019. PMID: 31515234. doi:10.2215/CJN.01610219

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。